April 6, 2023 – Biologica Technologies, developers and marketers of ProteiOS® growth factor and OsseoGEN® cellular bone matrix, announced today two significant, separate agreements signed with Premier Inc. and Academy Medical.
With Premier, Biologica has been awarded a Bone and Bone Substitute Implantable Product group purchasing agreement, effective April 1st, allowing Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the company’s ProteiOS, OsseoGEN, and ProGraft™ product lines. “I’m very excited to have been awarded an agreement for our product portfolio”, said Scott Cadotte, SVP, Sales and Marketing, “the fact that this has happened in the middle of a contracting cycle, speaks volumes to the desire for our products in hospitals”.
In addition, Biologica has partnered with Academy Medical, a Service-Disabled Veteran-Owned Small Business (SDVOSB) located in West Palm Beach, FL, to access the full complement of Veterans Administration (VA) Hospitals across the country.